News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,686 Results
Type
Article (60784)
Company Profile (103)
Press Release (639799)
Section
Business (197665)
Career Advice (3006)
Deals (34686)
Drug Delivery (107)
Drug Development (81993)
Employer Resources (169)
FDA (16040)
Job Trends (15050)
News (339602)
Policy (32788)
Tag
Academia (2751)
Alliances (49322)
Alzheimer's disease (1322)
Approvals (16021)
Artificial intelligence (231)
Bankruptcy (313)
Best Places to Work (11653)
Breast cancer (233)
Cancer (1805)
Cardiovascular disease (136)
Career advice (2539)
CAR-T (137)
Cell therapy (394)
Clinical research (65890)
Collaboration (705)
Compensation (272)
COVID-19 (2621)
C-suite (186)
Data (1697)
Diabetes (220)
Diagnostics (6387)
Earnings (75467)
Employer resources (149)
Events (107010)
Executive appointments (616)
FDA (17012)
Funding (632)
Gene therapy (269)
GLP-1 (695)
Government (4723)
Healthcare (19209)
Infectious disease (2737)
Inflammatory bowel disease (134)
Interviews (575)
IPO (15811)
Job creations (3846)
Job search strategy (2123)
Layoffs (495)
Legal (7847)
Lung cancer (258)
Manufacturing (239)
Medical device (13161)
Medtech (13166)
Mergers & acquisitions (19304)
Metabolic disorders (579)
Neuroscience (1752)
NextGen: Class of 2025 (6798)
Non-profit (4717)
Northern California (2074)
Obesity (312)
Opinion (240)
Patents (181)
People (60131)
Phase I (20440)
Phase II (28835)
Phase III (21579)
Pipeline (778)
Postmarket research (2882)
Preclinical (8873)
Radiopharmaceuticals (255)
Rare diseases (340)
Real estate (6265)
Regulatory (22057)
Research institute (2427)
Resumes & cover letters (460)
Southern California (1799)
Startups (3450)
United States (18587)
Vaccines (646)
Weight loss (224)
Date
Today (78)
Last 7 days (795)
Last 30 days (2696)
Last 365 days (33864)
2025 (5411)
2024 (34588)
2023 (38906)
2022 (49680)
2021 (54644)
2020 (53680)
2019 (47578)
2018 (36105)
2017 (33010)
2016 (32853)
2015 (38405)
2014 (32115)
2013 (28334)
2012 (29629)
2011 (29635)
2010 (28547)
Location
Africa (970)
Arizona (165)
Asia (40752)
Australia (7130)
California (4719)
Canada (1680)
China (420)
Colorado (221)
Connecticut (243)
Europe (94430)
Florida (714)
Georgia (174)
Illinois (493)
Indiana (265)
Japan (123)
Maryland (764)
Massachusetts (3563)
Michigan (203)
Minnesota (321)
New Jersey (1403)
New York (1386)
North Carolina (906)
Northern California (2074)
Ohio (167)
Pennsylvania (1059)
South America (1314)
Southern California (1799)
Texas (702)
Utah (155)
Washington State (458)
700,686 Results for "american academy of allergy asthma and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
February 20, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
February 21, 2025
·
5 min read
Press Releases
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
March 3, 2025
·
9 min read
Press Releases
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
February 10, 2025
·
6 min read
Press Releases
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
February 10, 2025
·
6 min read
Press Releases
ARS Pharmaceuticals to Showcase Innovation and Present Data on neffy® (epinephrine nasal spray) at 2025 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
February 19, 2025
·
9 min read
Genetown
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
Astria Therapeutics, Inc. today announced that it will present final STAR-0215 Phase 1a healthy subject data at the upcoming American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Washington, D.C. on February 23, 2024 at 3:15pm EST.
February 20, 2024
·
1 min read
Pharm Country
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Intrommune Therapeutics, Inc. today announced data from The First Study To Evaluate Oral Mucosal Immunotherapy (OMIT) For The Treatment Of Food Allergy has been selected as a Late Breaking Poster Presentation at the 2024 American Academy of Allergy, Asthma & Immunology in Washington, DC.
February 6, 2024
·
3 min read
Drug Development
KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
KalVista Pharmaceuticals, Inc. announced the acceptance of multiple abstracts at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting taking place in Washington, DC from February 23-26.
February 16, 2024
·
5 min read
Biotech Bay
Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper) is presenting results from three preclinical studies evaluating briquilimab, at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, being held February 23-26 in Washington, D.C.
February 23, 2024
·
8 min read
1 of 70,069
Next
